Skip to main content
Log in

Graves’ ophthalmopathy: Search for shared autoantigen(s) continues

  • Editorial
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bartalena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev 2000, 21: 168–99.

    CAS  PubMed  Google Scholar 

  2. Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves’ ophthalmopathy on quality of life. J Endocrinol Invest 2004, 27: 259–64.

    Article  CAS  PubMed  Google Scholar 

  3. Bartalena L, Marcocci C, Pinchera A. Graves’ ophthalmopathy: a preventable disease? Eur J Endocrinol 2002, 146: 457–61.

    Article  CAS  PubMed  Google Scholar 

  4. Bartalena L. Smoking and Graves’ disease. J Endocrinol Invest 2002, 25: 402.

    Article  PubMed  Google Scholar 

  5. Hegedus L, Brix TH, Vestergaard P. Relationship between cigarette smoking and Graves’ ophthalmopathy. J Endocrinol Invest 2004, 27: 265–71.

    Article  Google Scholar 

  6. Bartalena L, Tanda ML, Piantanida E, Lai A, Pinchera A. Relationship between management of hyperthyroidism and course of the ophthalmopathy. J Endocrinol Invest 2004, 27: 288–94.

    Article  CAS  PubMed  Google Scholar 

  7. Bartalena L, Marcocci C, Bogazzi F, et al. Relationship between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy. N Engl J Med 1998, 338: 73–8.

    Article  CAS  PubMed  Google Scholar 

  8. Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr Rev 2003, 24: 802–35.

    Article  CAS  PubMed  Google Scholar 

  9. Ajjan RA, Weetman AP. New understanding of the role of cytokines in the pathogenesis of Graves’ ophthalmopathy. J Endocrinol Invest 2004, 27: 227–45.

    Article  Google Scholar 

  10. Bahn RS. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves’ ophthalmopathy. J Endocrinol Invest 2004, 27: 216–20.

    Article  CAS  PubMed  Google Scholar 

  11. Ludgate M, Baker G. Inducing Graves’ ophthalmopathy. J Endocrinol Invest 2004, 27: 211–5.

    Article  CAS  PubMed  Google Scholar 

  12. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 2000, 52: 267–71.

    Article  CAS  Google Scholar 

  13. Mikozami T, Salvi M, Wall JR. Eye muscle antibodies in Graves’ ophthalmopathy: pathogenic or secondary epiphenomenon? J Endocrinol Invest 2004, 27: 221–9.

    Google Scholar 

  14. Marinò M, Chiovato L, Lisi S, Altea MA, Marcocci C, Pinchera A. Role of thyroglobulin in the pathogenesis of Graves’ ophthalmopathy: the hypothesis of Kriss revisited. J Endocrinol Invest 2004, 27: 230–6.

    Article  PubMed  Google Scholar 

  15. Lisi S, Botta R, Agretti P, et al. Poorly specific binding of thyroglobulin to orbital fibroblasts from patients with Graves’ ophthalmopathy. J Endocrinol Invest 2005, 28: 420–4.

    CAS  PubMed  Google Scholar 

  16. Bartalena L, Wiersinga WM, Pinchera A. Graves’ ophthalmopathy: state of the art and perspectives. J Endocrinol Invest 2004, 27: 295–301.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bartalena, L. Graves’ ophthalmopathy: Search for shared autoantigen(s) continues. J Endocrinol Invest 28, 396–397 (2005). https://doi.org/10.1007/BF03347216

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347216

Navigation